Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.200
0.00 (0.00%)
At close: Aug 3, 2026, 4:00 PM EDT
2.160
-0.040 (-1.82%)
After-hours: Aug 3, 2026, 5:14 PM EDT
Equillium Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
139.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 41.10M | 5.01M | 13.89% |
| Dec 31, 2023 | 36.08M | 20.33M | 128.97% |
| Dec 31, 2022 | 15.76M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caribou Biosciences | 11.20M |
| Cibus | 4.29M |
| NRx Pharmaceuticals | 2.29M |
| Kazia Therapeutics | 1.27M |
| Entera Bio | 42.00K |
| Genelux | 8.00K |
EQ News
- 13 days ago - Equillium initiated with a Buy at Clear Street - TheFly
- 21 days ago - Equillium initiated with an Overweight at Piper Sandler - TheFly
- 6 weeks ago - EQ Works Expands Multi-Year Partnership with Leading Canadian Publisher to Include SaaS License for ClearLake - Accesswire
- 2 months ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Equillium to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Equillium price target raised to $7 from $6 at Raymond James - TheFly
- 2 months ago - Leerink upgrades Equillium on ‘supportive’ ulcerative colitis data - TheFly
- 2 months ago - Equillium upgraded to Outperform from Market Perform at Leerink - TheFly